CIK 0001604191
- Non-accelerated filer
- Smaller reporting company
GridAI Technologies Corp.
Sign in to watch- Ticker
- GRDX
- Exchange
- Nasdaq
- Industry
- Electric & Other Services Combined
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464993860
- Phone
- +1 561-589-7020
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL
- Former names
- Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 139,545 shares at an average $1.35 ($188,472)
- 4 Open-market buy PRESIDENT AND CEO bought 38,583 shares at $1.30 ($49,969)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 20,000 shares at $1.31 ($26,214)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Open-market buy Director bought 9,000 shares at $1.41 ($12,690)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4/A Option exercise Director acquired 36,000 shares (option exercise)
Page 7 of 10 · 181 filings